Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Allocation Concealment in Clinical Trials—Reply — Ethan M. Balk (2002) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Allocation Concealment in Clinical Trials—Reply
Shared by
John P A Ioannidis
Stanford University
Allocation Concealment in Clinical Trials—Reply
Article
2002
en
Related publications
Letter
2002
Allocation Concealment in Clinical Trials
Kenneth F. Schulz
,
Douglas G. Altman
,
David Moher
Article
1998
Time Lag Bias in Publishing Clinical Trials—Reply
John P A Ioannidis
Article
Authors
+1 more
EB
Ethan M. Balk
PB
Peter A Bonis
JL
Joseph T. F. Lau
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
2001
Ethical Issues in the Reporting of Clinical Trials—Reply
Kenneth F. Schulz
,
David Moher
,
Douglas G. Altman
Letter
2022
Reply: Composite endpoints in clinical trials - simplicity or perfection?
Hironori Hara
,
Yoshinobu Onuma
,
Patrick W. Serruys
EuroIntervention
Letter
2013
Mega-Randomized Clinical Trials for Blockbuster Drugs—Reply
John P A Ioannidis
Discussion(0)
No comments yet. Be the first to comment.